Opinion: Are 71 NCI-Designated Cancer Centers Too Many?

A program to encourage transdisciplinary research at top cancer centers has evolved into a counterproductive national strategy for organizing cancer research.

| 3 min read
nci national cancer institute designated comprehensive cancer center

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: Red dots are cancer centers, blue are comprehensive cancer centers, and orange are basic laboratories.
NATIONAL CANCER INSTITUTE

After a six-year commitment and a $250 million investment, the University of Miami Medical School’s Sylvester Cancer Center recently became the 71st National Cancer Institute “designated” center. The NCI bestows the label on institutions that “meet rigorous standards for transdisciplinary, state-of-the-art research focused on developing new and better approaches to preventing, diagnosing, and treating cancer.” With only eight centers in 1972, the program now includes virtually every major cancer research center in the US; making it a defacto national strategy for organizing cancer research.

This is unfortunate. The goal may be rhetorically satisfying, but the reality is different. The program has evolved into a nationwide branding exercise, mostly signifying grant-writing endurance and adherence to metrics that skew scientific priorities and place centers in organizational straight jackets. University leaders, fundraisers, hospital executives, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • David Rubenson

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio